125 related articles for article (PubMed ID: 3288697)
1. Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells.
Quillet A; Presse F; Marchiol-Fournigault C; Harel-Bellan A; Benbunan M; Ploegh H; Fradelizi D
J Immunol; 1988 Jul; 141(1):17-20. PubMed ID: 3288697
[TBL] [Abstract][Full Text] [Related]
2. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
4. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution of H-2 class I expression by gene transfection decreases susceptibility to natural killer cells of an EL4 class I loss variant.
Sturmhöfel K; Hämmerling GJ
Eur J Immunol; 1990 Jan; 20(1):171-7. PubMed ID: 2106441
[TBL] [Abstract][Full Text] [Related]
6. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
[TBL] [Abstract][Full Text] [Related]
9. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
10. Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysis.
Miyagawa S; Nakai R; Matsunami K; Kusama T; Shirakura R
Transpl Immunol; 2003; 11(2):147-53. PubMed ID: 12799197
[TBL] [Abstract][Full Text] [Related]
11. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression.
Shimizu Y; DeMars R
Eur J Immunol; 1989 Mar; 19(3):447-51. PubMed ID: 2707298
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
14. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
Kaufman DS; Schoon RA; Leibson PJ
J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
[TBL] [Abstract][Full Text] [Related]
15. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis.
Storkus WJ; Wei M; Cresswell P; Dawson JR
Cell Immunol; 1996 Jan; 167(1):154-6. PubMed ID: 8548840
[TBL] [Abstract][Full Text] [Related]
16. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H
J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166
[TBL] [Abstract][Full Text] [Related]
17. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
[TBL] [Abstract][Full Text] [Related]
18. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
19. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity.
Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S
Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells.
Zdravkovic M; Aboagye-Mathiesen G; Guimond MJ; Hager H; Ebbesen P; Lala PK
Placenta; 1999; 20(5-6):431-40. PubMed ID: 10419808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
